| 000 | 01665 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250517174629.0 | ||
| 264 | 0 | _c20180705 | |
| 008 | 201807s 0 0 eng d | ||
| 022 | _a1879-0712 | ||
| 024 | 7 |
_a10.1016/j.ejphar.2017.09.031 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _avan Diemen, Marcus P J | |
| 245 | 0 | 0 |
_aValidation of a pharmacological model for mitochondrial dysfunction in healthy subjects using simvastatin: A randomized placebo-controlled proof-of-pharmacology study. _h[electronic resource] |
| 260 |
_bEuropean journal of pharmacology _cNov 2017 |
||
| 300 |
_a290-297 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Validation Study | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHand Strength |
| 650 | 0 | 4 | _aHealthy Volunteers |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMitochondria _xdrug effects |
| 650 | 0 | 4 |
_aOxygen Consumption _xdrug effects |
| 650 | 0 | 4 | _aSafety |
| 650 | 0 | 4 |
_aSimvastatin _xadverse effects |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aUbiquinone _xanalogs & derivatives |
| 700 | 1 | _aBerends, Cécile L | |
| 700 | 1 | _aAkram, Naila | |
| 700 | 1 | _aWezel, Joep | |
| 700 | 1 | _aTeeuwisse, Wouter M | |
| 700 | 1 | _aMik, Bert G | |
| 700 | 1 | _aKan, Hermien E | |
| 700 | 1 | _aWebb, Andrew | |
| 700 | 1 | _aBeenakker, Jan Willem M | |
| 700 | 1 | _aGroeneveld, Geert Jan | |
| 773 | 0 |
_tEuropean journal of pharmacology _gvol. 815 _gp. 290-297 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ejphar.2017.09.031 _zAvailable from publisher's website |
| 999 |
_c27597355 _d27597355 |
||